Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies.
| Website | http://www.invivyd.com |
| Employees | 188 (155 on RocketReach) |
| Founded | 2020 |
| Address | 209 Church St, New Haven, Connecticut 06510, US |
| Phone | +1 781-819-0080 |
| Industry | Biotechnology Research |
| Keywords | Viral Vectors, Biopharmaceutical, Rna Therapeutics, Predictive Modeling, Antiviral Therapies, Immunology, Vaccine Development, Infectious Disease Research, Drug Development, Biotechnology, Pharmaceutical Research, Clinical Trials, Therapeutics, Immunotherapies, Public Health, Global Health, Infectious Disease Control, Pandemic Preparedness |
| Competitors | Johnson & Johnson, Roche, Merck & Co., Inc., Pfizer, Sanofi, AstraZeneca, Regeneron, Moderna Therapeutics, Novavax, Zymergen, Inc. +34 more (view full list) |
Looking for a particular Invivyd employee's phone or email?
Invivyd Questions
William Duke is the CFO of Invivyd.
155 people are employed at Invivyd.
Invivyd is based in New Haven, Connecticut.
Top Invivyd Employees
-
William Duke
Chief Financial Officer at Invivyd
Shrewsbury, MA, US24 -
Robert Allen
Chief Scientific Officer at Invivyd
Waltham, MA, US25+ -
Kristie Kuhl
Chief Communications Officer (CCO) at Invivyd
Fairfield, CT, US25 -
Jill Andersen
Chief Legal Officer and Corporate Secretary at Invivyd
New York, NY, US25+ -
Michael Mina
Chief Medical Officer at Invivyd
Boston, MA, US5+3 -
Timothy Lee
Chief Commercial Officer (CCO) at Invivyd
Madison, CT, US23 -
35
-
Rachael Gerlach
Senior Vice President, Head of Regulatory Affairs at Invivyd
Louisville, KY, US35+
Related Companies
G2Crowd Trusted
300K+
Plugin Users
